Dupoiron, D., Stachowiak, A., Loewenstein, O., Ellery, A., Kremers, W., Bosse, B., & Hopp, M. (2017). A phase III randomized controlled study on the efficacy and improved bowel function of prolonged‐release (PR) oxycodone‐naloxone (up to 160/80 mg daily) vs oxycodone PR. Eur J Pain.
シカゴスタイル引用形Dupoiron, D., A. Stachowiak, O. Loewenstein, A. Ellery, W. Kremers, B. Bosse, , M. Hopp. "A Phase III Randomized Controlled Study On the Efficacy and Improved Bowel Function of Prolonged‐release (PR) Oxycodone‐naloxone (up to 160/80 Mg Daily) Vs Oxycodone PR." Eur J Pain 2017.
MLA引用形式Dupoiron, D., et al. "A Phase III Randomized Controlled Study On the Efficacy and Improved Bowel Function of Prolonged‐release (PR) Oxycodone‐naloxone (up to 160/80 Mg Daily) Vs Oxycodone PR." Eur J Pain 2017.